Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan L Riddle

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|July 23, 2003
Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptorsYvette V Ugarte, Kristi S Rau, Evan L Riddle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2007
Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesiclesTrent J Volz, Sarah J Farnsworth, Jill L King, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2006
Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensivesEvan L Riddle, Brinda K Rana, Kenton K Murthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2025
Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experienceBrandi L Vollmer, Tammy Hoyt, Timothy W West, et al.
Annals of Clinical and Translational Neurology|September 24, 2025
Annual 12-Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell CompositionRegina Berkovich, Tilman Schneider-Hohendorf, Eric Baetscher, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
A single methamphetamine administration rapidly decreases vesicular dopamine uptakeJeffrey M Brown, Evan L Riddle, Verónica Sandoval, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|July 23, 2003
Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptorsYvette V Ugarte, Kristi S Rau, Evan L Riddle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2007
Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesiclesTrent J Volz, Sarah J Farnsworth, Jill L King, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2006
Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensivesEvan L Riddle, Brinda K Rana, Kenton K Murthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2025
Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experienceBrandi L Vollmer, Tammy Hoyt, Timothy W West, et al.
Annals of Clinical and Translational Neurology|September 24, 2025
Annual 12-Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell CompositionRegina Berkovich, Tilman Schneider-Hohendorf, Eric Baetscher, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
A single methamphetamine administration rapidly decreases vesicular dopamine uptakeJeffrey M Brown, Evan L Riddle, Verónica Sandoval, et al.
Pageof 2